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Biodegradable magnesium coronary stents: from the design to the 
realisation 
Biodegradable cardiovascular stents in magnesium alloys constitute a promising 
option for a less intrusive treatment, due to their high compatibility to the body 
tissue and intrinsic dissolution in body fluids. The design and fabrication aspect 
of this medical device requires an integrated approach considering different 
aspects such as mechanical properties, corrosion behaviour and biocompatibility. 
This work gathers and summarizes a multi-disciplinary work carried out by three 
different research teams for the design and fabrication of magnesium stents. In 
particular the paper discusses the design of the novel stent mesh, the 
deformability study of the magnesium alloys for tubular raw material, and laser 
microcutting for the realization of the stent mesh. Although the results are not 
fully validated and the device fully tested, they show the feasibility of the used 
approaches, as the first prototype stents in magnesium alloy were produced 
successfully. 
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Introduction 
The efficacy of a medical device depends on several factors, which range from the 
proper identification of medical requirements, to the development of engineering 
solutions, and finally to the realization of the product itself. In the case of 
cardiovascular stents, the time scale between the conceptualization and the final 
implementation of the device is considerably longer, due to highly strict and demanding 
certification and clinical trial procedures. One of the main concerns regarding a 
cardiovascular stent application is the restenosis, which is the phenomenon of the 
arterial walls responding to the widening of the vessel to retrieve the previous patency 
due to a physiological response. The action called thrombosis manifests right after the 
tissue damage caused by the insertion of the stent. Due to the damage, blood clot 
aggregates and causes immediate narrowing in the vessel. If the occlusion appears in 3-
6 months after the implantation, the phenomenon is called in-stent restenosis and is due 
to inflammatory response of the body tissue to the stent presence. Preventing restenosis 
depends on the adequate design of the stent, but also on the chosen material which can 
ensure the biocompatibility with the body tissue. In particular the inclusion of elements 
in the stent material such as nickel, chrome, and molybdenum may trigger local immune 
response and inflammatory reactions, which may cause in turn the in-stent restenosis. 
Due to the importance of the material-body interactions, medical research has been 
widely focused on the material perspective to evaluate potential advantages and 
disadvantages of different alloys and elements as stent materials as well as the use of 
coatings to improve biocompatibility (Bertrand et al 1998, Lüscher et al 2007, Mani et al 
2007, O’Brien and Carroll 2008). The restenosis risk along with long-term mechanical 
instabilities is evidently more crucial when the vessel grows in pediatric patients. The 
key to prevent such risk is bioabsorbability which is mainly dependant on the used stent 
material. The idea of using medical devices that fulfil their required duty and dissolve in 
human body in the due time, has resulted in extensive research attempts in material 
science, stent design and production fields. Biocompatibility, on the other hand, is the 
required property that ensures the body tissue to tolerate the material without causing 
inflammations, leading to a less intrusive treatment. 
Magnesium, as an element already present in the human body, is highly 
compatible to the body tissues. Therefore, magnesium and its alloys as biodegradable 
and biocompatible implant materials represent a very attractive solution for their 
relatively low corrosion resistance in human body and for the good biocompatibility of 
both metal itself and the corrosion reaction products (Erne, Schier and Resink 2006, 
Staiger et al 2006, Witte 2010). Moreover as a metal, magnesium provides better 
mechanical performance with respect to the polymeric biodegradable materials. Due to 
such advantages, the field has been receiving more attention from the scientific 
community, leading the research to some of the first clinical trials (Di Mario et al 2004, 
Zartner et al 2005, Waksman et al 2006). However, most of the literature currently deals 
with the advantages of the use of the biodegradable magnesium stents, whereas there is 
lack of information regarding the design and manufacturing aspects of a magnesium 
stent. The performance of the magnesium stent depends on an extensive study on all the 
main aspects, namely material, design and fabrication. Moreover, such a study requires 
a good synergy between all the steps, and iterations that starting from the correct 
material selection and stent design lead to the final product. These three phases indeed 
have to match together to obtain a good agreement between mechanical properties, 
corrosion resistance and biocompatibility. In the literature works that simultaneously 
treats these different aspects regarding the magnesium stent from the concept to the 
fabricated device are absent. 
The present work investigates the overall realisation sequence of a new coronary 
stent in magnesium alloy based on a multidisciplinary approach that includes the three 
main aspects involved in the production of a new complex device: design, material and 
fabrication. The different aspects of the work were carried out by a research team that 
integrates together the three parts.  
The whole chain of design and fabrication, from conceptualization to realization 
is demonstrated. The paper initially presents the multidisciplinary approach employed to 
link different aspects of the realization of the new biodegradable Mg stent, from 
conceptualization to realization. Then, the specific design and manufacturing methods 
employed to realize the biodegradable stents with a novel mesh design in AZ31 
magnesium alloy are described. The new stent design was conceptualized and optimized 
through finite element analysis (FEA) for improved scaffolding properties. When the 
new stent was designed, the three main phases of the fabrication process were 
investigated: namely the extrusion of the precursor, the laser cutting of the stent mesh 
and finally the finishing operations. The extrusion capability of the AZ31 alloy was 
studied through hot compression tests. Determined parameters were used to extrude 
hollow small diameter tubes. The optimized mesh was cut on AZ31 tubes with 2.5 mm 
diameter and 0.2 mm thickness with a pulsed fiber laser. Chemical etching was applied 
on the material to remove the dross and re-molten material. The investigated sequence 
of steps enabling the production of magnesium alloy stents (MAS) puts in evidence the 
similarities of this procedure with the traditional one, and its own peculiarities, in the 
meantime offers extended insights to the industrialisation of this medical device. 
1. The implemented multidisciplinary approach for the new stent design and 
fabrication 
Three main aspects concerning a stent from conceptualization to realization can be 
identified as material, design, and fabrication (see Figure 1). For the specific case of 
biodegradable stents in Mg, the main issues concerning the three aspects can be listed 
as: 
 Material - choice of Mg alloy type. Issues regarding toxicity, corrosion resistance, 
material resistance, recoil. 
 Design of the mesh geometry. Issues regarding scaffolding ability, maximization 
of mass to control biodegradation rate. 
 Fabrication - determining the production cycle. Feasible process with high 
dimensional precision, including the necessary finishing steps. 
Although the roles of the three different aspects may seem discrete, they are in 
fact highly connected to the each other. The design of the stent is required to fully 
exploit the material characteristics, which should render the material a device that fulfils 
the certain duty of the stent. On the other hand, the design cannot reflect only the 
optimal geometric conditions to exploit the material mechanical properties to the 
highest, as long as it is not feasible for production. The fabrication methods should 
incorporate a production cycle capable of realizing and maintaining the material and 
design properties with required tolerance levels and quality, which reflect to the 
biocompatibility of the stent. 
The multidisciplinary work on biodegradable magnesium stents compared these 
issues in three consecutive steps. Material selection was based on a compromise 
between the chemical, mechanical, and corrosion properties of the material, ease of 
manufacturing, and availability of the raw material. The design was based on 2D 
morphing algorithm to define the best dimensions to optimize scaffolding ability with 
increasing in stent mass. Fabrication steps were identified by adapting extrusion, laser 
microcutting and chemical etching processes to the peculiarities of the chosen 
magnesium alloy. 
2. Choice of suitable Mg alloy  
A variety of Mg alloys are available in extruded bar or sheet forms, which may include 
common alloying elements such as Al, Zn, or Mn; as well as rare earth (RE) metals 
such as Ce, Pr, or Nd. The alloying elements determine mechanical performance, as 
yield stress, ultimate tensile strength and elongation depend highly on the alloying 
compounds. Moreover, the alloying elements influence the corrosion behaviour of the 
material. As a matter of fact pure Mg has a very high corrosion rate in physiological pH 
(Steiger et al. 2006). Including rare earth metals can effectively improve the corrosion 
resistance of the Mg alloy; however the low availability of the material is a concern that 
cannot be overseen. The formability of the alloy is another issue that needs to be 
addressed. Due to the low ductility of magnesium, the fabrication of tubular precursors 
in the dimensional range for a stent is difficult. Potentially, the chosen Mg alloy is 
supposed to exhibit a good compromise for the different aspects. 
The magnesium alloys currently under investigation as biomedical materials are mostly 
commercial alloys which have been applied for industrial applications. Almost none of 
the mentioned alloys have been originally developed for biodegradable implant material. 
However, the specialization of magnesium alloys for biomaterial applications, including 
composition design, processing route and testing standards is already under development. 
According to designation system of American Society for Testing and Materials (ASTM) 
under the standard ASTM B296 - 03(2008), the magnesium-based alloys can be divided 
into three major groups: pure magnesium (Mg) with traces of other elements, Al-
containing alloys and Al-free alloys (Polmear 1995). Due to the complex alloy 
composition and the limitations given by commercially available magnesium alloys, 
impurities (Ni, Cu, Fe and so on) may sum up to a total content of 0.3 wt.%. Very often 
these impurities are not listed in detail or even neglected. Although the given 
concentration of impurities are low compared to the physiological range in the body, the 
amount of these impurities has to be strictly controlled and kept at minimum level for 
biomedical applications. Elements such as beryllium and nickel should be avoided. 
In order to obtain higher mechanical properties and corrosion resistance, the alloying 
elements listed in Table 1 are usually considered in magnesium alloys for biomedical 
applications. A brief summary for pathophysiological and toxicological characteristics of 
these alloying elements in human body were summarized by Witte et al. (Witte 2010). 
According to known effects, the summary given in Table 1 could be supplied. The 
alloying elements to be added for developing biodegradable magnesium alloys are 
therefore limited to a few metals which are well known to be tolerated in the human body, 
including Ca, Zn, Mn and a small amount of RE. However, it is necessary to understand 
that the composition of alloy is even more complicated when rare earths are added to 
magnesium. Meanwhile, the processing routes should be strictly controlled in order to 
achieve the microstructural features required for high strength materials. 
In this work AZ31 Mg alloy was chosen as the stent material. This alloy provides a 
good compromise between the mechanical properties and corrosion behaviour. 
Moreover, AZ31 shows good deformability providing conditions for extruding the 
material to small precursors, which can be later on laser micromachined to the required 
mesh design. The commercial availability of the alloy in form of extruded bars is 
another positive aspect. As a drawback the inclusion of aluminium in the alloy reduces 
the biocompatibility of the device. 
3. A novel biodegradable Mg stent design 
The new stent consisted of five rings connected by curved links, presenting six 
peak-to-valley struts in the circular direction (Figure 2.a). This design was the product 
of a shape optimization procedure that was carried out on the 2D geometry with a 
morphing procedure (Wu et al 2010). Briefly, an optimization algorithm was applied to 
an initial bi-dimensional geometry to control its shape with the use of FEA with the 
main aim of satisfying the two controversial demands, namely related to strain and 
mass, that a MAS has compared to conventional stainless steel (SS) stents. Indeed, SS 
stents undergo large local strain (about 0.4-0.5) during stent expansion, while most 
magnesium alloys have much lower ultimate elongation (usually below 0.2). Excessive 
strain of MAS during expansion needs to be avoided. Furthermore, the elastic modulus 
of magnesium alloys is about 25% of that of SS, thus a MAS needs more material (e.g. 
widening stent strut) to provide adequate scaffolding. However, more material may also 
increase the strain during expansion. In an initial geometry, a strut unit was defined for 
optimization, with 3 main parts, curved (Cu), straight (St) and solidus (So) whose 
dimensions were varied to achieve geometry with the best performance (see Figure 2.c). 
The optimized design showed reduced maximum strain by 33% and increased 
scaffolding ability compared to an existing MAS design (Magic stent, Biotronic, Berlin, 
Germany) showed in Figure 2.b. 
The new stent design was numerically compared to an existing stent (Wu et al 
2011) in terms of degradation properties when virtually implanted in a vessel. For this 
purpose a continuum damage mechanics approach was applied (Gastaldi et al 2011). 
This approach takes into account both the uniform and the stress corrosion mechanisms. 
Indeed, these two aspects account for the micro galvanic mechanism experimentally 
observed in Mg alloys that results in corrosive attack uniformly distributed on the 
surface exposed to the aggressive environment and the localization of the corrosion 
attack in the areas of the material where the stress is more concentrated and the 
corrosion evolves mediated by the stress field. As seen in the FEM analysis reported in 
Figure 3, several parts of the conventional model are going to break (high damage 
locations indicated with red color), while the new stent model still keeps structural 
integrity. Results from this comparison showed that the new optimized stent design led 
to an increase of more than 100% in degradation time and accordingly it has improved 
scaffolding properties compared to the existing stent.  
4. Fabrication of stents in AZ31 alloy 
Cardiovascular stents are vastly produced by laser beam machining on tubular material, 
although they can be produced by many different processes which can involve braiding 
or knitting of wires, or cutting of tubular material by various methods such as electric 
discharge machining (EDM) or water jet, or may involve deposition and casting 
techniques (Martinez and Chaikof 2007, Stoeckel et al 2002). A generic production 
cycle can include various steps, though laser microcutting is the main process that 
realizes the stent mesh on tubular material. Depending on the cut quality, the laser cut 
stent can require finishing processes such as initially chemical etching and then 
electrochemical polishing. Heat treatment and surface coating steps are optional 
depending on the stent material (Figure 4). 
In the case of Mg stents, the production of the semi-finished tubular material 
plays a role as important as the consecutive machining of the stent mesh. In addition to 
the general difficulty of the extruding Mg alloys in the dimensions required for the stent 
applications, the extrusion process determines the microstructure of the material, which 
reflects to the corrosion behaviour of the stent in human body. 
The following illustrates the first three steps, raw-material production, laser 
microcutting and chemical etching, as depicted in the generic stent production cycle 
scheme. Since, the last two involve the generation and the finishing of the stent 
geometry, they have been investigated together.  
4.1. Extrusion of AZ31 tubes as stent precursors 
The experimental materials used in this study was AZ31B magnesium alloy which was 
supplied in the form of commercially available wrought bars having a diameter of 15 
mm. Hot-extrusion was carried out in the laboratory at die temperature of 410°C and 
average strain rate of 2.78·10-3s-1. A series of hollow tubes with outer diameter (D) 
ranging from 8 to 4 mm and inner diameter (d) from 6 to 3 mm were produced. The 
detailed experimental procedure for tube extrusion was reported in a previous work (Ge, 
Vedani, Vimercati 2012).  
Texture evolution from the as received to the extruded materials was investigated by 
Electron Backscattering Diffraction (EBSD) technique. Specimens sectioned parallel to 
the extrusion direction were electro-polished to be ready for the analysis.  To assess 
material performance strictly related to microstructural conditions matching the stent 
precursors, the mechanical properties were measured both in tension and compression 
on samples directly cut from extruded tubes to suitable gauge length. Tensile specimens 
had a gauge length of 30 mm for each extrusion diameter while compressive specimens 
had a reduced length of 20 mm to limit buckling phenomena during testing. For both of 
compressive and tensile modes, data were collected up to strain of 2% to avoid 
unwanted effects related to tube buckling in compression and sliding at grips in tension. 
After the tension-compression tests, microstructure was checked by optical and 
scanning electron microscopy to highlight possible modifications of microstructure 
induced by straining. 
4.1.1. Microstructure 
In Figure 5, the representative microstructure of extruded tube D4d3 is shown. Hereafter, 
the size of the tubes will be stated by a capital D followed by the size of the outer diameter 
and a d followed by inner diameter, both in mm. The micrographs are taken from mid-
thickness of longitudinal sections of AZ31 samples. The concurrent action of temperature 
and strain during extrusion initially promoted recrystallization and a relatively more 
refined microstructure with equiaxed grains after extrusion (as depicted in Figure 5.a.). 
The orientation maps gathered from EBSD analysis revealed a preferred orientation in 
AZ31 extruded alloy as depicted in Figure 5.b. The map clearly reveals that the 
predominant red grains feature their (0001) planes aligned parallel to the sample surface 
(longitudinal axial sections).  
Figure 6 shows the inverse pole figures in a direction normal to longitudinal axis obtained 
from starting alloy and after extrusion. It is revealed that AZ31 starting alloy had a 
condition with a weak texture given by the prismatic planes {10-10} and {2-1-10} aligned 
along the longitudinal axis of the bars (shown in Figure 6.a). After the laboratory-scale 
extrusion, the texture of the small-size tubes clearly changed as depicted in Figure 6.b. It 
is confirmed that a typical (0001) extrusion texture, featuring the basal plane aligned 
parallel to the extrusion direction was found in extruded tubes. 
 
4.1.2. Mechanical Properties 
Figure 7 depicts the initial part of the tensile and compression stress-strain curves 
recorded for AZ31 alloy. It is highlighted that yielding in compression occurs at 
significantly lower stress than in tension. Values of the 0.2% offset yield strength 
measured in tension and in compression are summarized in Table 2. Tests were performed 
on full-size cylindrical tube samples without machining a distinct gauge length due to 
small thickness limitations. Therefore, data about ultimate tensile strength and fracture 
elongation were not considered to be fully reliable and are not presented here. 
It can be readily observed that both the materials before and after extrusion feature a 
marked tension-compression asymmetry, the tensile yield strength being always 
significantly higher than that in compression. Extrusion led to a more visible drop in 
compressive strength, which is still lower than that in as received alloy.  
Studies about hcp crystal structure of magnesium (Wang and Huang 2007, Wu et al. 
2010) reported that the basal slip systems available at room temperature for plastic 
deformation do not satisfy the Taylor criterion requiring five independent easy slip 
systems for homogeneous and generalized ductility of polycrystalline metals. Other non 
basal slip systems such as the prismatic and pyramidal slip would offer six extra 
independent slip modes that could fulfil the requirement of plasticity and good 
workability. However, these non basal slip systems become available only at high 
temperature in Mg and Mg alloys (Lin, Hsu and Keh 2008) suggesting that shaping of 
the tubes cannot be performed other than by hot extrusion. The starting wrought bars 
here investigated exhibited weak preferential orientation of (10-10) and (2-1-10) planes 
along longitudinal direction. On the contrary, a well developed basal texture was found 
in the AZ31 alloy tubes from laboratory scale extrusion at 410°C. 
In addition to dislocation slip, it was also reported that magnesium exhibits a strong 
propensity for mechanical twinning. Indeed, it is well known that twinning deformation 
modes play an important role during the deformation of hexagonal metals (Meyers, 
Vöhringer, and Lubarda 2001). Despite the limited contribution of twinning itself to the 
total plasticity, the abrupt change of orientation due to twinning may give rise to the 
activation of other slip systems. The {10-12} <10-11> twin system is often observed in 
magnesium alloys and considered to be the preferential twinning system (Choudhary et 
al 2011). This kind of twinning preferably occurs when shear results from compressive 
stress applied parallel to the basal plane or from tensile stress applied perpendicularly to 
the same plane Wang and Huang 2007). By the texture condition detected in the present 
extruded tubes, crystallographic orientation in the sample does not allow easy twinning 
under tensile loading but twinning becomes favoured under compressive loading. 
Accordingly, the {10-12}<10-11> twinning was activated under compressive stress but 
not in tensile stress along the extrusion directions of the tubes, which resulted in abrupt 
decrease of yield stress in compression and marked compressive-tensile asymmetric 
behaviour. The occurrence of twinning was also clearly detected by metallographic 
observations (Vedani, Ge, Wu, and Petrini, 2012).  
4.2. Laser microcutting of the stent mesh on AZ31 and chemical etching  
Laser microcutting of cardiovascular stents is traditionally done using pulsed 
lasers that enable cut kerfs of a few tens of micrometers which is essential in order to 
realize such fine geometries (Dubey and Yavada 2008, Kathuria 2005, Raval et al 
2004). On the other hand, pulse duration along with the laser wavelength is the most 
important aspects that determine the cut quality. Lasers operating in ms-µs are the 
industrially applied solutions for stent cutting due to their high productivity. However 
ms-µs pulse durations produce lower cut quality as well as a high amount of dross and 
heat affection of processed material due to longer pulse durations. Lasers with ps-fs 
ultra-short pulses on the other hand supply a very high cutting quality due to ablation 
based process (Momma, Knop and Nolte 1999, Muhammad et al 2011), but they are not 
industrially diffused and are costly solutions. Meanwhile, ns pulse regime is a domain 
that has received little attention so far, even though its potentiality for a good trade off 
between high productivity and high quality. 
In this study focussed on cutting of the stent mesh, an active fiber laser operating 
in ns pulse regime with 50 W maximum average power (IPG- YLP-1/100/50/50) was 
used. In Table 3 the main specifications of the laser source are reported. The laser 
source was coupled with a cutting head (LaserMech) that housed a 60 mm focusing lens 
and a nozzle for process gas addition. In this configuration the obtained beam spot was 
23 µm, which allowed microcutting with small kerf widths. For positioning a linear and 
a rotary axis (Aerotech ALS and ACS series) with nanometric resolution were used. 
The microcutting setup is reported in detail in Figure 8. 
For the experiments, AZ31 tubes in 2.5 mm outer diameter and 0.2 mm thickness were 
used. Compared to the more traditional stent material stainless steel, which is 
commonly cut with oxygen, magnesium alloys require different laser microcutting 
conditions. Due to high melting temperature of the MgO, laser microcutting with 
oxygen as process gas was not found to be a feasible option. Such conditions result in 
uncut sections due to the generated oxide layer in the kerf (Demir et al. 2012). 
Therefore, cutting with an inert gas is an essential requirement working with 
magnesium alloys. 
An average power of 7.5 W with 25 kHz pulse repetition rate was found suitable for the 
cutting operation. Argon was used as assist gas with 7 bar pressure (purity 99.998%), 
and cutting speed of 2 mm/s was employed. An acidic solution of HNO3 (65% purity ) 
10 mL, ethanol 90 mL was preferred for chemical etching in order to remove dross and 
to clean the kerf, which was previously demonstrated to effectively remove dross on 
laser microcut AZ31 sheets (Lesma et al 2010). The complete separation as well as 
mesh strut polishing was aimed to be achieved by applying the etching solution. Figure 
9.a reports a SEM image of the AZ31 stent after laser microcutting. It can be observed 
that along the kerf area dross is present to a limited extent. A small amount of spatter is 
also evident near to cutting zones. The AZ31 stent after chemical etching is reported in 
Figure 9.b. It can be seen that the chemical etching successfully removed the dross on 
the surface, as the stent surface is clearly free of defects. However, along the stent 
thickness the walls show a roughness compared to the stent surfaces, which implies that 
the stent requires a further chemical polishing step to remove the asperities. On the 
other hand, the mesh design has been reproduced on the tube with high precision. 
5. Conclusion 
The present study describes the design and realization steps of a biodegradable 
and biocompatible stent in AZ31 alloy. Three main aspects to realize the biodegradable 
stent from the conceptual stage to the product have been identified as material, design 
and fabrication. A multi-disciplinary approach that incorporates different roles of 
material, design and fabrication research teams for the requirements of mechanical 
properties, production cycle and manufacturability issues has been employed. Following 
to this, the steps that involve the alloy selection, the design optimization, and the study 
of the AZ31 magnesium alloy for semi-finished tube extrusion and the realization of the 
final stent through laser microcutting and chemical etching have been explained. 
Specifically, the following conclusions can be drawn: 
 Among different magnesium alloys, AZ31 constitutes a good compromise 
between different material requirements, manufacturability and availability. 
 Stent design plays a critical role for mechanical properties and corrosion 
performance; shape optimization can potentially increase the maximum strain 
and scaffolding ability. 
 Preliminarily hot compression tests and laboratory extrusions allowed producing 
precursors of stents in the form of small tubes featuring a fine and equiaxed 
grain structure with increased hardness over the starting alloy. 
 Laser microcutting with a pulsed fiber laser is a suitable solution to cut AZ31. 
The relatively longer ns pulses result in a limited amount of dross around and 
inside the kerf. 
 Chemical etching with a HNO3 – ethanol solution is able to clean the dross and 
complete the scrap separation. The obtained stent requires further 
electropolishing stage to increase the edge quality. 
As a result of this multi-disciplinary work, the first prototype stents have been 
produced; this confirmed the feasibility of the applied approach. The control of the 
biodegradation rate is one of the points requiring further attention. The attempts of our 
research group will be focused to decelerate the corrosion rate of Mg alloy stents. For 
this purpose, the solutions involving the optimization of the microstructure of the raw 
material, the surface structuring and the adhesion of a biopolymer coating will be 
studied. In-vitro degradation of the stent materials will be evaluated for the choice of 
optimal combination of these solutions to be applied on the stent geometry. The 
interaction between the stent geometry and plausible combinations of the methods for 
optimizing the corrosion behaviour will be investigated by means of FEM simulations 
before animal trials and in vivo tests will be carried out.  
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Tables 
 
Table 1. Summary of the toxicology and pathophysiology of alloying elements. Adapt 
from Witte et al. 2008 
Element Pathophysiology/toxicology 
Alloying Elements 
Magnesium 
Normal blood serum level 0.73–1.06 mmol/L; 
Influences growth factor effectiveness; 
Co-regulator of energy metabolism, cell proliferation, protein synthesis, 
onset of DNA synthesis; 
Regulator of more than 350 proteins; 
Stabilizer of DNA and RNA ; 
Long-term influence on cellular reactions ; 
Cellular up-take via transient receptor potential (TRP) ion channels ; 
Co-regulator and activator of integrins (cell migration) . 
Calcium 
Normal serum level 0.919–0.993 mg/L; 
Most abundant mineral in the human body (1–1.1 kg) ; 
Mainly stored in bone, teeth ; 
Is tightly regulated by homeostasis of skeletal, renal and intestinal 
mechanism. 
Aluminum 
Normal blood serum level 2.1–4.8 lg/L; 
Established alloying element in titanium implants; 
Risk factor in generation of Alzheimer’s disease; 
Can cause muscle fiber damage; 
Decrease osteoclast viability; 
In magnesium alloys: mild foreign body reactions were observed in 
vivo. 
Zinc 
Normal blood serum level 12.4–17.4 lmol/L; 
Trace element; 
Essential for the immune system; 
Co-factor for specific enzymes in bone and cartilage; 
Neurotoxic at higher concentrations. 
Manganese 
Normal blood serum level <0.8 lg/L; 
Essential trace element; 
Important role in metabolic cycle of e.g. lipids, amino acids and 
carbohydrates; 
Influences the function of the immune system, bone growth, blood 
clotting, cellular energy regulation and neurotransmitter synthesis; 
Scavenger of free radicals in the manganese superoxide dismutase; 
Neurotoxic in higher concentration (manganism). 
Lithium 
Normal blood serum level 2–4 ng/g; 
Compound of drugs for treatment of psychiatric disorders; 
Overdosage causes nephrological or lung dysfunctions; 
Possible teratogenic effects. 
Rare earth 
elements Many rare earth elements exhibit anticancerogenic properties. 
 
Table 2. Tensile and compression 0.2% offset yield strength of the as received bars and 
extruded tubes.  
 As Received Tube D6d3 
Compressive Yield Stress (MPa) 109.6 91.8 
Tensile Yield Stress (MPa) 149.7 166.5 
Loss of yield strength (compression vs. tension, in 
%) 
26.8 44.9 
 
Table 3. Specifications of the laser microcutting system. 
IPG YLP-1/100/50/50 Q- switched laser 
Laser wavelength 1064 nm 
Maximum average power 50 W 
Maximum pulse energy 1 mJ 
Minimum pulse duration [FWHM] 100 ns 
Pulse repetition rate 20-80 kHz 
Beam quality factor (M2) 1.7 
Focused laser beam diameter 23 µm 
  
High precision positioning system 
Spindle accuracy ±72.7 µrad 
Linear axis accuracy 1 µm 
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Figure 1. The aspects and interactions within the multi-disciplinary approach used in the 
design and fabrication of the biodegradable Mg stents 
 
 
Figure 2. CAD models showing a) an existing coronary magnesium stent; b) of the new 
stent in the original configuration; and c) 2D dimensions of the new stent after shape 
optimization (adapted with permission from Wu et al). 
 
 
Figure 3. The comparison of degradation process of a conventional stent (upper panel) 
and the new stent design (lower panel) at the same degradation time using FEA. The 
legend indicates damage parameter with 0 meaning intact and 0.9 totally damaged. 
 
 
Figure 4. Production cycle of a cardiovascular stent. The process steps involved in this 
study are reported in the upper row. 
 
 
Figure 5. Microstructure of extruded D4d3 AZ31 tube on longitudinal section: a) optical 
micrograph; b) Orientation map from EBSD. 
  
Figure 6. Inverse pole figures taken from longitudinal sections of : a) The starting bar;  
b) Extruded tube. 
 
 
Figure 7. Tensile (T) and compression (C) stress-strain curves detected on starting bars 
and on hot-extruded tubes. 
 
 
Figure 8. Laser microcutting system. 
 
 
Figure 9. SEM images of the biodegradable AZ31 stent a) after laser microcutting, b) 
after chemical etching. c) Optical microscopy image of the stent 
